Open Access
Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review
Xia Wang, Shoujiang You, Shoichiro Sato, Jie Yang, Cheryl Carcel, Danni Zheng, Sohei Yoshimura, Craig S Anderson, Else Charlotte Sandset, Thompson Robinson, John Chalmers, Vijay K Sharma
DOI: 10.1136/svn-2017-000112 Published 22 March 2018
Xia Wang
1
The George Institute for Global Health, Newtown, New South Wales, Australia
2
Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia
Shoujiang You
3
Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, China
Shoichiro Sato
4
Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
Jie Yang
5
Department of Neurology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China
Cheryl Carcel
1
The George Institute for Global Health, Newtown, New South Wales, Australia
2
Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia
6
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
Danni Zheng
1
The George Institute for Global Health, Newtown, New South Wales, Australia
2
Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia
Sohei Yoshimura
1
The George Institute for Global Health, Newtown, New South Wales, Australia
2
Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia
4
Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
Craig S Anderson
1
The George Institute for Global Health, Newtown, New South Wales, Australia
2
Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia
6
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
7
The George Institute China, Peking University Health Science Center, Beijing, China
Else Charlotte Sandset
8
Department of Neurology, Oslo University Hospital, Oslo, Norway
Thompson Robinson
9
Department of Cardiovascular Sciences and NIHR Biomedical Research Unit for Cardiovascular Diseases, University of Leicester, Leicester, UK
John Chalmers
1
The George Institute for Global Health, Newtown, New South Wales, Australia
2
Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia
3
Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, China
Vijay K Sharma
10
Yong Loo Lin School of Medicine, National University of Singapore, Singapore
11
Division of Neurology, National University Hospital, Singapore

Submit a Response to This Article
No eLetters have been published for this article.
Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review
Xia Wang, Shoujiang You, Shoichiro Sato, Jie Yang, Cheryl Carcel, Danni Zheng, Sohei Yoshimura, Craig S Anderson, Else Charlotte Sandset, Thompson Robinson, John Chalmers, Vijay K Sharma
Stroke and Vascular Neurology Mar 2018, 3 (1) 28-33; DOI: 10.1136/svn-2017-000112

Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review
Xia Wang, Shoujiang You, Shoichiro Sato, Jie Yang, Cheryl Carcel, Danni Zheng, Sohei Yoshimura, Craig S Anderson, Else Charlotte Sandset, Thompson Robinson, John Chalmers, Vijay K Sharma
Stroke and Vascular Neurology Mar 2018, 3 (1) 28-33; DOI: 10.1136/svn-2017-000112
Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review
Xia Wang, Shoujiang You, Shoichiro Sato, Jie Yang, Cheryl Carcel, Danni Zheng, Sohei Yoshimura, Craig S Anderson, Else Charlotte Sandset, Thompson Robinson, John Chalmers, Vijay K Sharma
Stroke and Vascular Neurology Mar 2018, 3 (1) 28-33; DOI: 10.1136/svn-2017-000112